Among these drugs, cycloserine (enrichment score = − 0.844) and 11-deoxy-16,16-dimethylprostaglandin E2 (enrichment score = − 0.835) showed highly significant negative correlation and had potential to reverse the carcinoma status of GBM.
← all excerpts
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
1
—
—